ABILIFY 1 MG/ML ORAL SOLN MO 4 QL (750 per 30 days)
ABILIFY 10 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 15 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 2 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 20 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 30 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 5 MG TABLET MO 4 QL (30 per 30 days)
ABILIFY 9.75 MG/1.3 ML IM MO 4 QL (120 per 30 days)
ABILIFY DISCMELT 10 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 65
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
ABILIFY DISCMELT 15 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
ABILIFY MAINTENA 300 MG IM SUSPENSION,EXTENDED RELEASE MO 5 PA,QL (1 per 28 days)
ABILIFY MAINTENA 400 MG IM SUSPENSION,EXTENDED RELEASE MO 5 PA,QL (1 per 28 days)
acetaminoph-caff-dihydrocodein MO 4 QL (180 per 30 days)
acetaminophen-cod #2 tablet MO 3 QL (390 per 30 days)
acetaminophen-cod #3 tablet MO 3 QL (390 per 30 days)
acetaminophen-cod #4 tablet MO 3 QL (390 per 30 days)
acetaminophen-codeine solution MO 3 QL (5010 per 30 days)
acetaminophen-codeine solution MO 3 QL (5010 per 30 days)
acetaminophen-codeine solution MO 3 QL (5010 per 30 days)
acetaminophen-codeine solution MO 3 QL (5010 per 30 days)
acetaminophen-codeine solution MO 3 QL (5010 per 30 days)
alfentanil 500 mcg/ml amp MO 3 QL (450 per 30 days)
ali-flex tablet MO 2
alprazolam 0.25 mg tablet MO 3 QL (120 per 30 days)
alprazolam 0.5 mg tablet MO 3 QL (120 per 30 days)
alprazolam 1 mg tablet MO 3 QL (240 per 30 days)
alprazolam 2 mg tablet MO 3 QL (150 per 30 days)
ALSUMA 6 MG/0.5 ML SUB-Q PEN INJECTOR MO 4 QL (6 per 30 days)
amantadine 100 mg capsule MO 3
amantadine 100 mg tablet MO 3
amantadine 50 mg/5 ml syrup MO 3
amitriptyline hcl 10 mg tab MO 1 PA
amitriptyline hcl 100 mg tab MO 1 PA
amitriptyline hcl 150 mg tab MO 1 PA
amitriptyline hcl 25 mg tab MO 1 PA
amitriptyline hcl 50 mg tab MO 1 PA
amitriptyline hcl 75 mg tab MO 1 PA
amoxapine 100 mg tablet MO 2
amoxapine 150 mg tablet MO 2
amoxapine 25 mg tablet MO 2
amoxapine 50 mg tablet MO 2
amphetamine salt combo 10 mg tablet MO 3 QL (90 per 30 days)
amphetamine salt combo 12.5 mg tablet MO 3 QL (90 per 30 days)
amphetamine salt combo 15 mg tablet MO 3 QL (90 per 30 days)
66 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
amphetamine salt combo 20 mg tablet MO 3 QL (90 per 30 days)
amphetamine salt combo 30 mg tablet MO 3 QL (60 per 30 days)
amphetamine salt combo 5 mg tablet MO 3 QL (90 per 30 days)
amphetamine salt combo 7.5 mg tablet MO 3 QL (90 per 30 days)
anabar 20 mg-300 mg-200 mg tablet MO 1
APOKYN 10 MG/ML SUBQ CARTRIDGE MO 5 QL (60 per 30 days)
ARTHROTEC 50 50 MG-200 MCG TABLET,FILM-COATED MO 4
ARTHROTEC 75 75 MG-200 MCG TABLET,FILM-COATED MO 4
astramorph-pf 0.5 mg/ml injection MO 1 QL (7200 per 30 days)
astramorph-pf 1 mg/ml injection MO 1 QL (3600 per 30 days)
AVINZA 120 MG CAPSULE, EXTENDED RELEASE MO 3 QL (60 per 30 days)
AVINZA 30 MG CAPSULE, EXTENDED RELEASE MO 3 QL (30 per 30 days)
AVINZA 45 MG CAPSULE, EXTENDED RELEASE MO 3 QL (30 per 30 days)
AVINZA 60 MG CAPSULE, EXTENDED RELEASE MO 3 QL (60 per 30 days)
AVINZA 75 MG CAPSULE, EXTENDED RELEASE MO 3 QL (60 per 30 days)
AVINZA 90 MG CAPSULE, EXTENDED RELEASE MO 3 QL (60 per 30 days)
AZILECT 0.5 MG TABLET MO 3
AZILECT 1 MG TABLET MO 3
BANZEL 200 MG TABLET MO 4 PA,QL (480 per 30 days)
BANZEL 40 MG/ML ORAL SUSP MO 5 PA,QL (2760 per 30 days)
BANZEL 400 MG TABLET MO 5 PA,QL (240 per 30 days)
benztropine 2 mg/2 ml ampule MO 1
benztropine mes 0.5 mg tab MO 2 PA
benztropine mes 1 mg tablet MO 2 PA
benztropine mes 2 mg tablet MO 2 PA
bromocriptine 2.5 mg tablet MO 4
bromocriptine 5 mg capsule MO 4
budeprion sr 100 mg tablet,extended release MO 3 QL (120 per 30 days)
budeprion sr 150 mg tablet,extended release MO 3 QL (90 per 30 days)
budeprion xl 150 mg tablet MO 3 QL (90 per 30 days)
budeprion xl 300 mg tablet MO 3 QL (90 per 30 days)
BUPRENEX 0.3 MG/ML INJECTION MO 5 PA,QL (240 per 30 days)
buprenorphine 0.3 mg/ml syrn MO 4 PA,QL (240 per 30 days)
buprenorphine 0.3 mg/ml vial MO 4 PA,QL (240 per 30 days)
buprenorphine 2 mg tablet sl MO 4 PA,QL (90 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 67
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
buprenorphine 8 mg tablet sl MO 4 PA,QL (90 per 30 days)
buproban 150 mg tablet,extended release MO 3 QL (90 per 30 days)
bupropion hcl 100 mg tablet MO 3 QL (180 per 30 days)
bupropion hcl 75 mg tablet MO 3
bupropion hcl sr 100 mg tablet MO 3 QL (120 per 30 days)
bupropion hcl sr 200 mg tab MO 3 QL (60 per 30 days)
bupropion hcl xl 150 mg tablet MO 3 QL (90 per 30 days)
bupropion hcl xl 300 mg tablet MO 3 QL (90 per 30 days)
bupropion sr 150 mg tablet MO 3 QL (90 per 30 days)
buspirone hcl 10 mg tablet MO 2
buspirone hcl 15 mg tablet MO 2
buspirone hcl 30 mg tablet MO 2
buspirone hcl 5 mg tablet MO 2
buspirone hcl 7.5 mg tablet MO 2
butalb-acetamin-caff 50-325-40 MO 4 PA,QL (180 per 30 days)
butalb-acetamin-caff 50-500-40 MO 4 PA,QL (180 per 30 days)
butalbit-acetaminophen-caff cp MO 4 PA,QL (180 per 30 days)
butalbital compound 50 mg-325 mg-40 mg tablet MO 4 PA,QL (180 per 30 days)
butalbital-asa-caffeine cap MO 4 PA,QL (180 per 30 days)
butalbital-asa-caffeine tablet MO 4 PA,QL (180 per 30 days)
BUTISOL 30 MG TABLET MO 4 PA
BUTISOL 30 MG/5 ML ELIXIR MO 4 PA
BUTISOL 50 MG TABLET MO 4 PA
butorphanol 1 mg/ml vial MO 3 QL (960 per 30 days)
butorphanol 10 mg/ml spray MO 3 QL (5 per 28 days)
butorphanol 2 mg/ml vial MO 3 QL (480 per 30 days)
CAFCIT 60 MG/3 ML (20 MG/ML) IV MO 4
CAFCIT 60 MG/3 ML (20 MG/ML) ORAL SOLN MO 4
caff-sod benzoate 500 mg vl MO 1
caffeine cit 60 mg/3 ml oral MO 1
caffeine cit 60 mg/3 ml vial MO 1
CAMPRAL 333 MG TABLET,DELAYED RELEASE MO 4
CAPITAL WITH CODEINE 120 MG-12 MG/5 ML ORAL SUSP MO 4 QL (5010 per 30 days)
carbamazepine 100 mg tab chew MO 2
carbamazepine 100 mg/5 ml susp MO 2
68 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
carbamazepine 200 mg tablet MO 2
carbamazepine er 100 mg cap MO 4
carbamazepine er 200 mg cap MO 4
carbamazepine er 300 mg cap MO 4
carbamazepine xr 200 mg tablet MO 3
carbamazepine xr 400 mg tablet MO 3
CARBATROL 100 MG CAPSULE, EXTENDED RELEASE MO 4
CARBATROL 200 MG CAPSULE, EXTENDED RELEASE MO 4
CARBATROL 300 MG CAPSULE, EXTENDED RELEASE MO 4
carbidopa-levo 10-100 mg odt MO 3
carbidopa-levo 25-100 mg odt MO 3
carbidopa-levo 25-250 mg odt MO 3
carbidopa-levo er 25-100 tab MO 3
carbidopa-levo er 50-200 tab MO 3
carbidopa-levodopa 10-100 tab MO 3
carbidopa-levodopa 25-100 tab MO 3
carbidopa-levodopa 25-250 tab MO 3
CELEBREX 100 MG CAPSULE MO 3 QL (60 per 30 days)
CELEBREX 200 MG CAPSULE MO 3 QL (60 per 30 days)
CELEBREX 400 MG CAPSULE MO 3 QL (60 per 30 days)
CELEBREX 50 MG CAPSULE MO 3 QL (60 per 30 days)
CELONTIN 300 MG CAPSULE MO 4
chlorpromazine 10 mg tablet MO 3 B vs D
chlorpromazine 100 mg tablet MO 3
chlorpromazine 200 mg tablet MO 3
chlorpromazine 25 mg tablet MO 3 B vs D
chlorpromazine 25 mg/ml amp MO 2
chlorpromazine 50 mg tablet MO 3
choline mag trisal 500 mg tb MO 2
choline mag trisal 750 mg tb MO 2
choline mag trisal liquid MO 2
citalopram hbr 10 mg tablet MO 1 QL (30 per 30 days)
citalopram hbr 10 mg/5 ml soln MO 1
citalopram hbr 20 mg tablet MO 1 QL (60 per 30 days)
citalopram hbr 40 mg tablet MO 1 QL (30 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 69
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
CLINORIL 200 MG TABLET MO 4
clomipramine 25 mg capsule MO 2 PA
clomipramine 50 mg capsule MO 2 PA
clomipramine 75 mg capsule MO 2 PA
clonazepam 0.125 mg dis tab MO 4
clonazepam 0.25 mg odt MO 4
clonazepam 0.5 mg dis tablet MO 4
clonazepam 0.5 mg tablet MO 3
clonazepam 1 mg dis tablet MO 4
clonazepam 1 mg tablet MO 3
clonazepam 2 mg odt MO 4
clonazepam 2 mg tablet MO 3
clonidine 1000 mcg/10 ml vial MO 1
clorazepate 15 mg tablet MO 4
clorazepate 3.75 mg tablet MO 4
clorazepate 7.5 mg tablet MO 4
clozapine 100 mg tablet MO 3
clozapine 200 mg tablet MO 3
clozapine 25 mg tablet MO 3
clozapine 50 mg tablet MO 3
clozapine odt 100 mg tablet MO 4 ST
clozapine odt 12.5 mg tablet MO 4 ST
clozapine odt 25 mg tablet MO 4 ST
codeine sulfate 15 mg tablet MO 3 QL (360 per 30 days)
codeine sulfate 30 mg tablet MO 3 QL (360 per 30 days)
codeine sulfate 60 mg tablet MO 3 QL (180 per 30 days)
COGENTIN 2 MG/2 ML INJECTION MO 4 PA
CYCLOSET 0.8 MG TABLET MO 4 ST,QL (180 per 30 days)
CYMBALTA 20 MG CAPSULE,DELAYED RELEASE MO 3 QL (60 per 30 days)
CYMBALTA 30 MG CAPSULE,DELAYED RELEASE MO 3 QL (60 per 30 days)
CYMBALTA 60 MG CAPSULE,DELAYED RELEASE MO 3 QL (60 per 30 days)
d-amphetamine er 10 mg capsule MO 4 QL (180 per 30 days)
d-amphetamine er 15 mg capsule MO 4 QL (120 per 30 days)
d-amphetamine er 5 mg capsule MO 3 QL (60 per 30 days)
DAYTRANA 10 MG/9 HR DAILY PATCH MO 4 QL (30 per 30 days)
70 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
DAYTRANA 15 MG/9 HR DAILY PATCH MO 4 QL (30 per 30 days)
DAYTRANA 20 MG/9 HR DAILY PATCH MO 4 QL (30 per 30 days)
DAYTRANA 30 MG/9 HR DAILY PATCH MO 4 QL (30 per 30 days)
DEPACON 500 MG/5 ML (100 MG/ML) IV MO 4
depade 50 mg tablet MO 4
DEPAKENE 250 MG CAPSULE MO 4
DEPAKENE 250 MG/5 ML ORAL SOLN MO 4
desipramine 10 mg tablet MO 4
desipramine 100 mg tablet MO 4
desipramine 150 mg tablet MO 4
desipramine 25 mg tablet MO 4
desipramine 50 mg tablet MO 4
desipramine 75 mg tablet MO 4
dexmethylphenidate 10 mg tab MO 2 QL (60 per 30 days)
dexmethylphenidate 2.5 mg tab MO 2 QL (60 per 30 days)
dexmethylphenidate 5 mg tab MO 2 QL (60 per 30 days)
dextroamp-amphet er 10 mg cap MO 4 QL (30 per 30 days)
dextroamp-amphet er 15 mg cap MO 4 QL (30 per 30 days)
dextroamp-amphet er 20 mg cap MO 4 QL (60 per 30 days)
dextroamp-amphet er 25 mg cap MO 4 QL (60 per 30 days)
dextroamp-amphet er 30 mg cap MO 4 QL (60 per 30 days)
dextroamp-amphet er 5 mg cap MO 4 QL (30 per 30 days)
dextroamphetamine 10 mg tab MO 4 QL (180 per 30 days)
dextroamphetamine 5 mg tab MO 4 QL (150 per 30 days)
diazepam 10 mg rectal gel MO 4
diazepam 10 mg tablet MO 4 QL (120 per 30 days)
diazepam 2 mg tablet MO 4 QL (90 per 30 days)
diazepam 2.5 mg rectal gel MO 4
diazepam 20 mg rectal gel MO 4
diazepam 5 mg tablet MO 4 QL (90 per 30 days)
diazepam 5 mg/5 ml solution MO 4 QL (1200 per 30 days)
diazepam intensol 5 mg/ml oral concentrate MO 4 QL (1200 per 30 days)
diclofenac pot 50 mg tablet MO 2
diclofenac sod ec 25 mg tab MO 2
diclofenac sod ec 50 mg tab MO 2
2014 HUMANA FORMULARY UPDATED 08/2013 - 71
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
diclofenac sod ec 75 mg tab MO 2
diclofenac sod er 100 mg tab MO 2
diclofenac-misoprost 50-0.2 tb MO 4
diclofenac-misoprost 75-0.2 tb MO 4
diflunisal 500 mg tablet MO 4
DILANTIN 30 MG CAPSULE MO 4
DILANTIN EXTENDED 100 MG CAPSULE MO 4
DILANTIN INFATABS 50 MG CHEWABLE TABLET MO 4
DILANTIN-125 125 MG/5 ML ORAL SUSP MO 4
divalproex sod dr 125 mg tab MO 2
divalproex sod dr 250 mg tab MO 2
divalproex sod dr 500 mg tab MO 2
divalproex sod er 250 mg tab MO 2
divalproex sod er 500 mg tab MO 2
divalproex sodium 125 mg cap MO 2
DOLOPHINE 10 MG TABLET MO 2 QL (240 per 30 days)
DOLOPHINE 5 MG TABLET MO 2 QL (480 per 30 days)
DOPRAM 20 MG/ML IV MO 4
doxapram hcl 20 mg/ml vial MO 4
doxepin 10 mg capsule MO 2 PA
doxepin 10 mg/ml oral conc MO 2 PA
doxepin 100 mg capsule MO 2 PA
doxepin 150 mg capsule MO 2 PA
doxepin 25 mg capsule MO 2 PA
doxepin 50 mg capsule MO 2 PA
doxepin 75 mg capsule MO 2 PA
droperidol 2.5 mg/ml vial MO 1
DURABAC CAPSULE MO 4
DURACLON (PF) 1,000 MCG/10 ML (100 MCG/ML) EPIDURAL MO 4
DURAMORPH (PF) 0.5 MG/ML INJECTION MO 4 QL (7200 per 30 days)
DURAMORPH (PF) 1 MG/ML INJECTION MO 4 QL (3600 per 30 days)
duraxin 20 mg-300 mg-200 mg capsule MO 2
EC-NAPROSYN 375 MG TABLET,DELAYED RELEASE MO 4 PA
EC-NAPROSYN 500 MG TABLET,DELAYED RELEASE GB,MO 4 PA
ed-flex capsule MO 2
72 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
EMSAM 12 MG/24 HR TRANSDERM 24 HR PATCH MO 5 QL (30 per 30 days)
EMSAM 6 MG/24 HR TRANSDERM 24 HR PATCH MO 4 QL (30 per 30 days)
EMSAM 9 MG/24 HR TRANSDERM 24 HR PATCH MO 5 QL (30 per 30 days)
endocet 10 mg-325 mg tablet MO 3 QL (360 per 30 days)
endocet 10 mg-650 mg tablet MO 3 QL (180 per 30 days)
endocet 5 mg-325 mg tablet MO 3 QL (360 per 30 days)
endocet 7.5 mg-325 mg tablet MO 3 QL (360 per 30 days)
endocet 7.5 mg-500 mg tablet MO 3 QL (240 per 30 days)
entacapone 200 mg tablet MO 4 QL (300 per 30 days)
epitol 200 mg tablet MO 1
EQUETRO 100 MG CAPSULE, EXTENDED RELEASE GB,MO 4
EQUETRO 200 MG CAPSULE, EXTENDED RELEASE MO 4
EQUETRO 300 MG CAPSULE, EXTENDED RELEASE MO 4
escitalopram 10 mg tablet MO 2 QL (45 per 30 days)
escitalopram 20 mg tablet MO 2 QL (30 per 30 days)
escitalopram 5 mg tablet MO 2 QL (30 per 30 days)
escitalopram oxalate 5 mg/5 ml MO 4 QL (600 per 30 days)
ethosuximide 250 mg capsule MO 2
ethosuximide 250 mg/5 ml soln MO 2
etodolac 200 mg capsule MO 2
etodolac 300 mg capsule MO 2
etodolac 400 mg tablet MO 2
etodolac 500 mg tablet MO 2
etodolac er 400 mg tablet MO 3
etodolac er 500 mg tablet MO 3
etodolac er 600 mg tablet MO 3
FANAPT 1 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 10 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 12 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABLETS IN A DOSE PACK MO 4 PA,QL (60 per 30 days)
FANAPT 2 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 4 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 6 MG TABLET MO 4 PA,QL (60 per 30 days)
FANAPT 8 MG TABLET MO 4 PA,QL (60 per 30 days)
FAZACLO 100 MG DISINTEGRATING TABLET MO 4 ST
2014 HUMANA
FAZACLO 12.5 MG DISINTEGRATING TABLET MO 4 ST
FAZACLO 150 MG DISINTEGRATING TABLET MO 4 ST
FAZACLO 200 MG DISINTEGRATING TABLET MO 4 ST
FAZACLO 25 MG DISINTEGRATING TABLET MO 4 ST
felbamate 400 mg tablet MO 4
felbamate 600 mg tablet MO 4
felbamate 600 mg/5 ml susp MO 4
FELBATOL 400 MG TABLET MO 5
FELBATOL 600 MG TABLET MO 5
FELBATOL 600 MG/5 ML ORAL SUSP MO 5
fenoprofen 600 mg tablet MO 4
fentanyl 0.05 mg/ml ampul MO 4 QL (720 per 30 days)
fentanyl 0.05 mg/ml syringe MO 4 QL (240 per 30 days)
fentanyl 100 mcg/hr patch MO 4 QL (20 per 30 days)
fentanyl 12 mcg/hr patch MO 4 QL (20 per 30 days)
fentanyl 25 mcg/hr patch MO 4 QL (20 per 30 days)
fentanyl 50 mcg/hr patch MO 4 QL (20 per 30 days)
fentanyl 75 mcg/hr patch MO 4 QL (20 per 30 days)
fentanyl cit otfc 1,200 mcg MO 5 PA,QL (120 per 30 days)
fentanyl cit otfc 1,600 mcg MO 5 PA,QL (120 per 30 days)
fentanyl citrate otfc 200 mcg MO 5 PA,QL (120 per 30 days)
fentanyl citrate otfc 400 mcg MO 5 PA,QL (120 per 30 days)
fentanyl citrate otfc 600 mcg MO 5 PA,QL (120 per 30 days)
fentanyl citrate otfc 800 mcg MO 5 PA,QL (120 per 30 days)
FLECTOR 1.3 %TRANSDERM 12 HR PATCH MO 4 QL (60 per 30 days)
FLEXTRA PLUS CAPSULE MO 4
FLEXTRA-650 TABLET MO 4
flumazenil 0.1 mg/ml vial MO 2
fluoxetine 20 mg/5 ml solution MO 2
fluoxetine dr 90 mg capsule MO 4 QL (4 per 28 days)
fluoxetine hcl 10 mg capsule MO 2 QL (60 per 30 days)
fluoxetine hcl 10 mg tablet MO 2
fluoxetine hcl 20 mg capsule MO 2 QL (120 per 30 days)
fluoxetine hcl 20 mg tablet MO 3
fluoxetine hcl 40 mg capsule MO 2 QL (60 per 30 days)
74 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
fluoxetine hcl 60 mg tablet MO 2 QL (30 per 30 days)
fluphenazine 1 mg tablet MO 2
fluphenazine 10 mg tablet MO 2
fluphenazine 2.5 mg tablet MO 2
fluphenazine 2.5 mg/5 ml elix MO 2
fluphenazine 2.5 mg/ml vial MO 2
fluphenazine 5 mg tablet MO 2
fluphenazine 5 mg/ml conc MO 2
fluphenazine dec 25 mg/ml vl MO 4
flurbiprofen 100 mg tablet MO 2
flurbiprofen 50 mg tablet MO 2
fluvoxamine er 100 mg capsule MO 3 QL (60 per 30 days)
fluvoxamine er 150 mg capsule MO 3 QL (60 per 30 days)
fluvoxamine maleate 100 mg tab MO 3 QL (90 per 30 days)
fluvoxamine maleate 25 mg tab MO 3 QL (90 per 30 days)
fluvoxamine maleate 50 mg tab MO 3 QL (90 per 30 days)
FOCALIN XR 10 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 15 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 20 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 25 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 30 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 35 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 40 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
FOCALIN XR 5 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
fosphenytoin 100 mg pe/2 ml vl MO 1
fosphenytoin 500 mg pe/10 ml MO 1
gabapentin 100 mg capsule MO 2 QL (270 per 30 days)
gabapentin 250 mg/5 ml soln MO 3
gabapentin 250 mg/5 ml soln MO 3
gabapentin 300 mg capsule MO 2 QL (270 per 30 days)
gabapentin 300 mg/6 ml soln MO 3
gabapentin 400 mg capsule MO 2 QL (270 per 30 days)
gabapentin 600 mg tablet MO 2 QL (180 per 30 days)
gabapentin 800 mg tablet MO 2 QL (180 per 30 days)
GEODON 20 MG IM MO 4
2014 HUMANA FORMULARY UPDATED 08/2013 - 75
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
HALDOL 5 MG/ML INJECTION MO 4
HALDOL DECANOATE 100 MG/ML IM MO 4 PA
HALDOL DECANOATE 50 MG/ML IM MO 4
haloperidol 0.5 mg tablet MO 2
haloperidol 1 mg tablet MO 2
haloperidol 10 mg tablet MO 2
haloperidol 2 mg tablet MO 2
haloperidol 20 mg tablet MO 2
haloperidol 5 mg tablet MO 2
haloperidol dec 100 mg/ml vial MO 4
haloperidol dec 50 mg/ml vial MO 4
haloperidol lac 2 mg/ml conc MO 2
haloperidol lac 5 mg/ml vial MO 2
hydrocodon-acetaminoph 2.5-325 MO 3 QL (360 per 30 days)
hydrocodon-acetaminoph 2.5-500 MO 3 QL (240 per 30 days)
hydrocodon-acetaminoph 7.5-300 MO 4 QL (390 per 30 days)
hydrocodon-acetaminoph 7.5-325 MO 3 QL (360 per 30 days)
hydrocodon-acetaminoph 7.5-500 MO 3 QL (240 per 30 days)
hydrocodon-acetaminoph 7.5-650 MO 3 QL (180 per 30 days)
hydrocodon-acetaminoph 7.5-750 MO 3 QL (150 per 30 days)
hydrocodon-acetaminophen 5-300 MO 4 QL (390 per 30 days)
hydrocodon-acetaminophen 5-325 MO 3 QL (360 per 30 days)
hydrocodon-acetaminophen 5-500 MO 3 QL (240 per 30 days)
hydrocodon-acetaminophn 10-300 MO 4 QL (390 per 30 days)
hydrocodon-acetaminophn 10-325 MO 3 QL (360 per 30 days)
hydrocodon-acetaminophn 10-500 MO 3 QL (240 per 30 days)
hydrocodon-acetaminophn 10-650 MO 3 QL (180 per 30 days)
hydrocodon-acetaminophn 10-660 MO 3 QL (180 per 30 days)
hydrocodon-acetaminophn 10-750 MO 4 QL (150 per 30 days)
hydrocodone-ibuprofen 7.5-200 MO 3 QL (150 per 30 days)
hydromorphone 0.5 mg/0.5 ml MO 4 QL (720 per 30 days)
hydromorphone 1 mg/ml syringe MO 4 QL (720 per 30 days)
hydromorphone 2 mg tablet MO 4 QL (360 per 30 days)
hydromorphone 2 mg/ml syringe MO 4 QL (360 per 30 days)
hydromorphone 2 mg/ml vial MO 4 QL (360 per 30 days)
76 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
hydromorphone 3 mg suppos MO 4 QL (120 per 30 days)
hydromorphone 4 mg tablet MO 4 QL (360 per 30 days)
hydromorphone 4 mg/ml syrin MO 4 QL (180 per 30 days)
hydromorphone 50 mg/5 ml vial MO 4 QL (144 per 30 days)
hydromorphone 8 mg tablet MO 4 QL (240 per 30 days)
hydromorphone hcl 1 mg/ml amp MO 4 QL (720 per 30 days)
hydromorphone hcl 2 mg/ml vl MO 4 QL (360 per 30 days)
hydromorphone hcl 4 mg/ml amp MO 4 QL (180 per 30 days)
ibuprofen 100 mg/5 ml susp MO 1
ibuprofen 400 mg tablet MO 1
ibuprofen 600 mg tablet MO 1
ibuprofen 800 mg tablet MO 1
imipramine hcl 10 mg tablet MO 2 PA
imipramine hcl 25 mg tablet MO 2 PA
imipramine hcl 50 mg tablet MO 2 PA
imipramine pamoate 100 mg cap MO 4 PA
imipramine pamoate 125 mg cap MO 4 PA
imipramine pamoate 150 mg cap MO 4 PA
imipramine pamoate 75 mg cap MO 4 PA
INDOCIN 1 MG IV SOLUTION MO 4
INDOCIN 50 MG RECTAL SUPPOSITORY MO 4
INFUMORPH P/F 10 MG/ML INJECTION MO 4 QL (360 per 30 days)
INFUMORPH P/F 25 MG/ML INJECTION MO 4 QL (150 per 30 days)
INVEGA 1.5 MG TABLET,EXTENDED RELEASE MO 4 ST,QL (30 per 30 days)
INVEGA 3 MG TABLET,EXTENDED RELEASE MO 4 ST,QL (30 per 30 days)
INVEGA 6 MG TABLET,EXTENDED RELEASE MO 4 ST,QL (60 per 30 days)
INVEGA 9 MG TABLET,EXTENDED RELEASE MO 4 ST,QL (30 per 30 days)
INVEGA SUSTENNA 117 MG/0.75 ML IM SYRINGE MO 5 QL (2 per 30 days)
INVEGA SUSTENNA 156 MG/ML IM SYRINGE MO 5 QL (2 per 30 days)
INVEGA SUSTENNA 234 MG/1.5 ML IM SYRINGE MO 5 QL (2 per 30 days)
INVEGA SUSTENNA 39 MG/0.25 ML IM SYRINGE MO 4 QL (2 per 30 days)
INVEGA SUSTENNA 78 MG/0.5 ML IM SYRINGE MO 4 QL (2 per 30 days)
ketoprofen 50 mg capsule MO 2
ketoprofen 75 mg capsule MO 2
ketoprofen er 200 mg capsule MO 3
2014 HUMANA FORMULARY UPDATED 08/2013 - 77
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
LAMICTAL ODT 100 MG DISINTEGRATING TABLET MO 4
LAMICTAL ODT 200 MG DISINTEGRATING TABLET MO 4
LAMICTAL ODT 25 MG DISINTEGRATING TABLET MO 4
LAMICTAL ODT 50 MG DISINTEGRATING TABLET MO 4
LAMICTAL ODT STARTER (BLUE) 25 MG (21)-50 MG (7)
TABLET,DISINTEGRATING MO
4
LAMICTAL ODT STARTER (GREEN) 50 MG (42)-100 MG (14)
TAB,DISINTEGRATING MO
4
LAMICTAL ODT STARTER (ORANGE) 25 MG(14)-50 MG(14)-100 MG(7)
TAB,DISINT MO
4
LAMICTAL STARTER (BLUE) KIT 25 MG (35) TABLETS IN A DOSE PACK MO 4
LAMICTAL STARTER (GREEN) KIT 25 MG (84)-100 MG (14) TABLETS,
DOSE PACK MO
4
LAMICTAL STARTER (ORANGE) KIT 25 MG (42)-100 MG (7) TABLETS,
DOSE PACK MO
4
LAMICTAL XR STARTER (BLUE) 25 MG (21)-50 MG (7) TABLET,EXTEND
RELEASE MO
4
LAMICTAL XR STARTER (GREEN) 50 MG(14)-100 MG(14)-200MG(7)
TAB,EXT.REL MO
4
LAMICTAL XR STARTER (ORANGE) 25MG (14)-50MG (14)-100MG (7)
TAB,EXT.REL MO
4
lamotrigine 100 mg tablet MO 2
lamotrigine 150 mg tablet MO 2
lamotrigine 200 mg tablet MO 2
lamotrigine 25 mg disper tab MO 2
lamotrigine 25 mg tablet MO 2
lamotrigine 25 mg tb start kit MO 2
lamotrigine 5 mg disper tablet MO 2
lamotrigine er 100 mg tablet MO 4
lamotrigine er 200 mg tablet MO 4
lamotrigine er 25 mg tablet MO 4
lamotrigine er 250 mg tablet MO 4
lamotrigine er 300 mg tablet MO 4
lamotrigine er 50 mg tablet MO 4
LATUDA 120 MG TABLET MO 4 PA,QL (30 per 30 days)
LATUDA 20 MG TABLET MO 4 PA,QL (30 per 30 days)
LATUDA 40 MG TABLET MO 4 PA,QL (30 per 30 days)
78 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
LATUDA 80 MG TABLET MO 4 PA,QL (60 per 30 days)
LAZANDA 100 MCG/SPRAY NASAL SPRAY MO 5 PA,QL (30 per 30 days)
LAZANDA 400 MCG/SPRAY NASAL SPRAY MO 5 PA,QL (30 per 30 days)
LEVACET 500 MG-250 MG-150 MG-32.5 MG TABLET MO 4
levetiraceta-nacl 1,000 mg/100 MO 2
levetiraceta-nacl 1,500 mg/100 MO 2
levetiracetam 1,000 mg tablet MO 2
levetiracetam 100 mg/ml soln MO 4
levetiracetam 250 mg tablet MO 2
levetiracetam 500 mg tablet MO 2
levetiracetam 500 mg/5 ml soln MO 4
levetiracetam 500 mg/5 ml vial MO 4
levetiracetam 750 mg tablet MO 2
levetiracetam er 500 mg tablet MO 2
levetiracetam er 750 mg tablet MO 2
levetiracetam-nacl 500 mg/100 MO 2
levorphanol 2 mg tablet MO 3 QL (240 per 30 days)
lithium 8 meq/5 ml solution MO 2
lithium 8 meq/5 ml solution MO 2
lithium carbonate 150 mg cap MO 2
lithium carbonate 300 mg cap MO 2
lithium carbonate 300 mg tab MO 2
lithium carbonate 600 mg cap MO 2
lithium carbonate er 300 mg tb MO 2
lithium er 450 mg tablet MO 2
lorazepam 0.5 mg tablet MO 3 QL (90 per 30 days)
lorazepam 1 mg tablet MO 3 QL (90 per 30 days)
lorazepam 2 mg tablet MO 3 QL (150 per 30 days)
loxapine 10 mg capsule MO 3
loxapine 25 mg capsule MO 3
loxapine 5 mg capsule MO 3
loxapine 50 mg capsule MO 3
LOXITANE 10 MG CAPSULE MO 4
LOXITANE 25 MG CAPSULE MO 3
LOXITANE 5 MG CAPSULE MO 4
2014 HUMANA FORMULARY UPDATED 08/2013 - 79
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
LOXITANE 50 MG CAPSULE MO 3
LUNESTA 1 MG TABLET MO 4 PA
LUNESTA 2 MG TABLET MO 4 PA
LUNESTA 3 MG TABLET MO 4 PA
LUVOX CR 100 MG CAPSULE,EXTENDED RELEASE MO 3 QL (60 per 30 days)
LUVOX CR 150 MG CAPSULE,EXTENDED RELEASE MO 3 QL (60 per 30 days)
LYRICA 100 MG CAPSULE MO 4 QL (90 per 30 days)
LYRICA 150 MG CAPSULE MO 4 QL (90 per 30 days)
LYRICA 20 MG/ML ORAL SOLN MO 4 QL (900 per 30 days)
LYRICA 200 MG CAPSULE MO 4 QL (90 per 30 days)
LYRICA 225 MG CAPSULE MO 4 QL (60 per 30 days)
LYRICA 25 MG CAPSULE MO 4 QL (90 per 30 days)
LYRICA 300 MG CAPSULE MO 4 QL (60 per 30 days)
LYRICA 50 MG CAPSULE MO 4 QL (90 per 30 days)
LYRICA 75 MG CAPSULE MO 4 QL (90 per 30 days)
magnesium chl 200 mg/ml vial MO 2
magnesium sulf 4% iv soln MO 2
magnesium sulf 8% iv soln MO 2
magnesium sulfate 50% syringe MO 2
magnesium sulfate 50% vial MO 2
magnesium-d5w 1 gm/100 ml soln MO 2
maprotiline 25 mg tablet MO 4
maprotiline 50 mg tablet MO 4
maprotiline 75 mg tablet MO 2
MARPLAN 10 MG TABLET MO 4
MAXIDONE 10 MG-750 MG TABLET MO 4 QL (150 per 30 days)
meclofenamate 100 mg capsule MO 4
meclofenamate 50 mg capsule MO 2
meloxicam 15 mg tablet MO 1 QL (30 per 30 days)
meloxicam 7.5 mg tablet MO 1 QL (60 per 30 days)
meloxicam 7.5 mg/5 ml susp MO 1 QL (300 per 30 days)
METADATE CD 10 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
METADATE CD 20 MG CAPSULE,EXTENDED RELEASE MO 4 QL (60 per 30 days)
METADATE CD 30 MG CAPSULE,EXTENDED RELEASE MO 4 QL (60 per 30 days)
METADATE CD 40 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
80 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
METADATE CD 50 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
METADATE CD 60 MG CAPSULE,EXTENDED RELEASE MO 4 QL (30 per 30 days)
methadone 10 mg/5 ml solution MO 2 QL (1800 per 30 days)
methadone 10 mg/ml oral conc MO 2 QL (360 per 30 days)
methadone 5 mg/5 ml solution MO 2 QL (3600 per 30 days)
methadone hcl 10 mg tablet MO 2 QL (240 per 30 days)
methadone hcl 10 mg/ml vial MO 2 QL (360 per 30 days)
methadone hcl 5 mg tablet MO 2 QL (480 per 30 days)
methadone intensol 10 mg/ml oral concentrate MO 2 QL (360 per 30 days)
METHADOSE 10 MG/ML ORAL CONCENTRATE MO 3 QL (360 per 30 days)
methamphetamine 5 mg tablet MO 4 QL (150 per 30 days)
methyl salicylate liquid MO 1
METHYLIN 10 MG CHEWABLE TABLET MO 4 QL (180 per 30 days)
METHYLIN 2.5 MG CHEWABLE TABLET MO 4 QL (150 per 30 days)
METHYLIN 5 MG CHEWABLE TABLET MO 4 QL (150 per 30 days)
methylphenidate 10 mg tablet MO 2 QL (90 per 30 days)
methylphenidate 10 mg/5 ml sol MO 4 QL (900 per 30 days)
methylphenidate 20 mg tablet MO 2 QL (90 per 30 days)
methylphenidate 5 mg tablet MO 2 QL (90 per 30 days)
methylphenidate 5 mg/5 ml soln MO 4 QL (1800 per 30 days)
methylphenidate er 10 mg tab MO 4 QL (90 per 30 days)
methylphenidate er 18 mg tab MO 4 QL (30 per 30 days)
methylphenidate er 20 mg tab MO 4 QL (90 per 30 days)
methylphenidate er 27 mg tab MO 4 QL (30 per 30 days)
methylphenidate er 36 mg tab MO 4 QL (60 per 30 days)
methylphenidate er 54 mg tab MO 4 QL (30 per 30 days)
methylphenidate er-la 20 mg cp MO 4 QL (30 per 30 days)
methylphenidate er-la 30 mg cp MO 4 QL (60 per 30 days)
methylphenidate er-la 40 mg cp MO 4 QL (30 per 30 days)
mirtazapine 15 mg odt MO 4 QL (30 per 30 days)
mirtazapine 15 mg tablet MO 2 QL (30 per 30 days)
mirtazapine 30 mg odt MO 4 QL (30 per 30 days)
mirtazapine 30 mg tablet MO 2 QL (30 per 30 days)
mirtazapine 45 mg odt MO 4 QL (30 per 30 days)
mirtazapine 45 mg tablet MO 2 QL (30 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 81
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
mirtazapine 7.5 mg tablet MO 2
MOBAN 10 MG TABLET MO 4
MOBAN 50 MG TABLET MO 4
modafinil 100 mg tablet MO 4 PA,QL (60 per 30 days)
modafinil 200 mg tablet MO 4 PA,QL (60 per 30 days)
morphine 0.5 mg/ml vial MO 3 QL (7200 per 30 days)
morphine 1 mg/ml syringe MO 3 QL (3600 per 30 days)
morphine 1 mg/ml vial p-f MO 3 QL (3600 per 30 days)
morphine 1 mg/ml-d5w 100 ml MO 3 QL (3600 per 30 days)
morphine 10 mg/ml carpuject MO 3 QL (360 per 30 days)
morphine 10 mg/ml syringe MO 3 QL (360 per 30 days)
morphine 10 mg/ml vial MO 3 QL (360 per 30 days)
morphine 15 mg/ml carpuject MO 3 QL (240 per 30 days)
morphine 15 mg/ml syringe MO 3 QL (240 per 30 days)
morphine 2 mg/ml carpuject MO 3 QL (1800 per 30 days)
morphine 2 mg/ml syringe MO 3 QL (1800 per 30 days)
morphine 300 mg/20 ml vial MO 3 QL (600 per 30 days)
morphine 4 mg/ml carpuject MO 3 QL (900 per 30 days)
morphine 4 mg/ml syringe MO 3 QL (900 per 30 days)
morphine 5 mg/ml vial MO 3 QL (720 per 30 days)
morphine 8 mg/ml syringe MO 3 QL (450 per 30 days)
morphine 8 mg/ml syringe MO 3 QL (450 per 30 days)
morphine 8 mg/ml vial MO 3 QL (450 per 30 days)
morphine sulf 10 mg suppos MO 3 QL (180 per 30 days)
morphine sulf 10 mg/5 ml soln MO 3 QL (2700 per 30 days)
morphine sulf 100 mg/5 ml soln MO 3 QL (600 per 30 days)
morphine sulf 20 mg suppos MO 3 QL (180 per 30 days)
morphine sulf 20 mg/5 ml soln MO 3 QL (1350 per 30 days)
morphine sulf 30 mg suppos MO 3 QL (180 per 30 days)
morphine sulf 5 mg suppos MO 3 QL (180 per 30 days)
morphine sulf er 100 mg tablet MO 3 QL (180 per 30 days)
morphine sulf er 15 mg tablet MO 3 QL (120 per 30 days)
morphine sulf er 200 mg tablet MO 3 QL (90 per 30 days)
morphine sulf er 30 mg tablet MO 3 QL (120 per 30 days)
morphine sulf er 60 mg tablet MO 3 QL (120 per 30 days)
82 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
morphine sulfate 1 mg/ml vial MO 3 QL (3600 per 30 days)
morphine sulfate 25 mg/ml vial MO 3 QL (150 per 30 days)
morphine sulfate 25 mg/ml vl MO 3 QL (150 per 30 days)
morphine sulfate 50 mg/ml vial MO 3 QL (240 per 30 days)
morphine sulfate er 100 mg cap MO 3 QL (60 per 30 days)
morphine sulfate er 20 mg cap MO 3 QL (60 per 30 days)
morphine sulfate er 30 mg cap MO 3 QL (60 per 30 days)
morphine sulfate er 50 mg cap MO 3 QL (60 per 30 days)
morphine sulfate er 60 mg cap MO 3 QL (60 per 30 days)
morphine sulfate er 80 mg cap MO 3 QL (60 per 30 days)
morphine sulfate ir 15 mg tab MO 3 QL (180 per 30 days)
morphine sulfate ir 30 mg tab MO 3 QL (180 per 30 days)
mst 600 tablet MO 2
nabumetone 500 mg tablet MO 2
nabumetone 750 mg tablet MO 2
nalbuphine 100 mg/10 ml vial MO 4 QL (240 per 30 days)
nalbuphine 200 mg/10 ml vial MO 4 QL (120 per 30 days)
NALFON 200 MG PULVULE MO 4
NALFON 400 MG CAPSULE MO 4
naloxone 0.4 mg/ml syringe MO 2
naloxone 0.4 mg/ml vial MO 2
naloxone 2 mg/2 ml syringe MO 2
naltrexone 50 mg tablet MO 2
NAMENDA 10 MG TABLET MO 3 QL (60 per 30 days)
NAMENDA 10 MG/5 ML ORAL SOLN MO 3 QL (360 per 30 days)
NAMENDA 5 MG TABLET MO 3 QL (60 per 30 days)
NAMENDA TITRATION PAK 5 MG-10 MG TABLETS IN A DOSE PACK MO 3 QL (98 per 30 days)
NAMENDA XR 14 MG CAPSULE SPRINKLE,ER 24HR MO 3 QL (30 per 30 days)
NAMENDA XR 21 MG CAPSULE SPRINKLE,ER 24HR MO 3 QL (30 per 30 days)
NAMENDA XR 28 MG CAPSULE SPRINKLE,ER 24HR MO 3 QL (30 per 30 days)
NAMENDA XR 7 MG CAPSULE SPRINKLE,ER 24HR MO 3 QL (30 per 30 days)
NAMENDA XR 7 MG-14 MG-21 MG-28 MG CAPSULE,SPRINKLE,ER
24HR,DOSE PACK MO
3 QL (28 per 28 days)
naproxen 125 mg/5 ml suspen MO 2
naproxen 250 mg tablet MO 2
naproxen 375 mg tablet MO 2
2014 HUMANA FORMULARY UPDATED 08/2013 - 83
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
naproxen 500 mg tablet MO 2
naproxen dr 375 mg tablet MO 2
naproxen dr 500 mg tablet MO 2
naproxen sodium 275 mg tab MO 2
naproxen sodium 550 mg tab MO 2
naratriptan hcl 1 mg tablet MO 4 QL (9 per 30 days)
naratriptan hcl 2.5 mg tablet MO 4 QL (9 per 30 days)
NAVANE 2 MG CAPSULE MO 4
NAVANE 20 MG CAPSULE MO 4
nefazodone hcl 100 mg tablet MO 4
nefazodone hcl 150 mg tablet MO 4
nefazodone hcl 200 mg tablet MO 4
nefazodone hcl 250 mg tablet MO 4
nefazodone hcl 50 mg tablet MO 2
NEUPRO 1 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEUPRO 2 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEUPRO 3 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEUPRO 4 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEUPRO 6 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEUPRO 8 MG/24 HOUR TRANSDERM 24 HR PATCH MO 4 PA,QL (30 per 30 days)
NEURONTIN 250 MG/5 ML ORAL SOLN MO 4
NORPRAMIN 10 MG TABLET MO 4
NORPRAMIN 100 MG TABLET GB,MO 4
NORPRAMIN 150 MG TABLET MO 4
NORPRAMIN 25 MG TABLET GB,MO 4
NORPRAMIN 50 MG TABLET GB,MO 4
NORPRAMIN 75 MG TABLET MO 4
nortriptyline 10 mg/5 ml sol MO 1
nortriptyline hcl 10 mg cap MO 2
nortriptyline hcl 25 mg cap MO 2
nortriptyline hcl 50 mg cap MO 2
nortriptyline hcl 75 mg cap MO 2
NUEDEXTA 20 MG-10 MG CAPSULE MO 3 QL (60 per 30 days)
NUVIGIL 150 MG TABLET MO 4 PA,QL (30 per 30 days)
NUVIGIL 250 MG TABLET MO 4 PA,QL (30 per 30 days)
84 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
NUVIGIL 50 MG TABLET MO 4 PA,QL (60 per 30 days)
olanzapine 10 mg tablet MO 3 QL (30 per 30 days)
olanzapine 10 mg vial MO 3 QL (60 per 30 days)
olanzapine 15 mg tablet MO 3 QL (60 per 30 days)
olanzapine 2.5 mg tablet MO 3 QL (30 per 30 days)
olanzapine 20 mg tablet MO 3 QL (60 per 30 days)
olanzapine 5 mg tablet MO 3 QL (30 per 30 days)
olanzapine 7.5 mg tablet MO 3 QL (30 per 30 days)
olanzapine odt 10 mg tablet MO 4 QL (30 per 30 days)
olanzapine odt 15 mg tablet MO 4 QL (60 per 30 days)
olanzapine odt 20 mg tablet MO 4 QL (60 per 30 days)
olanzapine odt 5 mg tablet MO 4 QL (30 per 30 days)
olanzapine-fluoxetine 12-25 mg MO 4 QL (30 per 30 days)
olanzapine-fluoxetine 12-50 mg MO 4 QL (30 per 30 days)
olanzapine-fluoxetine 3-25 mg MO 4 QL (30 per 30 days)
olanzapine-fluoxetine 6-25 mg MO 4 QL (30 per 30 days)
olanzapine-fluoxetine 6-50 mg MO 4 QL (30 per 30 days)
ONFI 10 MG TABLET MO 4 PA,QL (60 per 30 days)
ONFI 20 MG TABLET MO 4 PA,QL (60 per 30 days)
ONFI 5 MG TABLET MO 4 PA,QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 10 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 15 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 85
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 20 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 30 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 40 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
OPANA ER 7.5 MG TABLET, CRUSH RESISTANT, EXTENDED RELEASE MO 3 QL (60 per 30 days)
ORAP 1 MG TABLET GB,MO 4
ORAP 2 MG TABLET MO 4
oxaprozin 600 mg tablet MO 3
oxazepam 10 mg capsule MO 4
oxazepam 15 mg capsule MO 4
oxazepam 30 mg capsule MO 4
oxcarbazepine 150 mg tablet MO 3
oxcarbazepine 300 mg tablet MO 3
86 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
oxcarbazepine 300 mg/5 ml susp MO 2
oxcarbazepine 600 mg tablet MO 3
oxycodon-acetaminophen 2.5-325 MO 3 QL (360 per 30 days)
oxycodon-acetaminophen 7.5-325 MO 3 QL (360 per 30 days)
oxycodon-acetaminophen 7.5-500 MO 3 QL (240 per 30 days)
oxycodone hcl 10 mg tablet MO 3 QL (360 per 30 days)
oxycodone hcl 100 mg/5 ml soln MO 4 QL (270 per 30 days)
oxycodone hcl 15 mg tablet MO 3 QL (360 per 30 days)
oxycodone hcl 20 mg tablet MO 3 QL (360 per 30 days)
oxycodone hcl 30 mg tablet MO 3 QL (360 per 30 days)
oxycodone hcl 5 mg capsule MO 4 QL (360 per 30 days)
oxycodone hcl 5 mg tablet MO 3 QL (360 per 30 days)
oxycodone hcl 5 mg/5 ml soln MO 3 QL (5400 per 30 days)
oxycodone-acetaminophen 10-325 MO 3 QL (360 per 30 days)
oxycodone-acetaminophen 10-650 MO 3 QL (180 per 30 days)
oxycodone-acetaminophen 5-325 MO 3 QL (360 per 30 days)
oxycodone-acetaminophen 5-500 MO 3 QL (240 per 30 days)
oxycodone-asa 4.5-0.38-325 tab MO 3 QL (360 per 30 days)
oxycodone-aspirin 4.83-325 mg MO 4 QL (360 per 30 days)
oxycodone-ibuprofen 5-400 tab MO 3 QL (240 per 30 days)
paroxetine cr 12.5 mg tablet MO 4 QL (60 per 30 days)
paroxetine cr 25 mg tablet MO 4 QL (90 per 30 days)
paroxetine cr 37.5 mg tablet MO 4 QL (60 per 30 days)
paroxetine hcl 10 mg tablet MO 2 QL (30 per 30 days)
paroxetine hcl 10 mg/5 ml susp MO 2
paroxetine hcl 20 mg tablet MO 2 QL (30 per 30 days)
paroxetine hcl 30 mg tablet MO 2 QL (60 per 30 days)
paroxetine hcl 40 mg tablet MO 2 QL (60 per 30 days)
PAXIL 10 MG/5 ML ORAL SUSP MO 4
PEGANONE 250 MG TABLET MO 4
PENNSAID 1.5 %TOPICAL DROPS MO 4
perphen-amitrip 2 mg-10 mg tab MO 3 PA
perphen-amitrip 2 mg-25 mg tab MO 3 PA
perphen-amitrip 4 mg-10 mg tab MO 3 PA
perphen-amitrip 4 mg-25 mg tab MO 3 PA
2014 HUMANA FORMULARY UPDATED 08/2013 - 87
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
perphen-amitrip 4 mg-50 mg tab MO 3 PA
perphenazine 16 mg tablet MO 4
perphenazine 2 mg tablet MO 4
perphenazine 4 mg tablet MO 4
perphenazine 8 mg tablet MO 4
phenelzine sulfate 15 mg tab MO 3
phenobarbital 100 mg tablet MO 3 PA,QL (90 per 30 days)
phenobarbital 15 mg tablet MO 3 PA,QL (120 per 30 days)
phenobarbital 16.2 mg tablet MO 3 PA,QL (90 per 30 days)
phenobarbital 20 mg/5 ml elix MO 3 PA,QL (1500 per 30 days)
phenobarbital 30 mg tablet MO 3 PA,QL (300 per 30 days)
phenobarbital 32.4 mg tablet MO 3 PA,QL (90 per 30 days)
phenobarbital 60 mg tablet MO 3 PA,QL (120 per 30 days)
phenobarbital 64.8 mg tablet MO 3 PA,QL (90 per 30 days)
phenobarbital 97.2 mg tablet MO 3 PA,QL (90 per 30 days)
PHENYTEK 200 MG CAPSULE MO 3
PHENYTEK 300 MG CAPSULE MO 3
phenytoin 100 mg/4 ml susp MO 2
phenytoin 125 mg/5 ml susp MO 2
phenytoin 50 mg tablet chew MO 4
phenytoin 50 mg/ml syringe MO 2
phenytoin 50 mg/ml vial MO 2
phenytoin sod ext 100 mg cap MO 2
phenytoin sod ext 200 mg cap MO 2
phenytoin sod ext 300 mg cap MO 2
piroxicam 10 mg capsule MO 3
piroxicam 20 mg capsule MO 3
POTIGA 200 MG TABLET MO 4 PA
POTIGA 300 MG TABLET MO 4 PA
POTIGA 400 MG TABLET MO 4 PA
POTIGA 50 MG TABLET MO 4 PA
pramipexole 0.125 mg tablet MO 2
pramipexole 0.25 mg tablet MO 2
pramipexole 0.5 mg tablet MO 2
pramipexole 0.75 mg tablet MO 2
88 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
pramipexole 1 mg tablet MO 2
pramipexole 1.5 mg tablet MO 2
PRIALT 100 MCG/ML INTRATHECAL MO 5 B vs D
PRIALT 25 MCG/ML INTRATHECAL MO 5 B vs D
primidone 250 mg tablet MO 2
primidone 50 mg tablet MO 2
PRISTIQ 100 MG TABLET,EXTENDED RELEASE MO 4 QL (30 per 30 days)
PRISTIQ 50 MG TABLET,EXTENDED RELEASE MO 4 QL (30 per 30 days)
protriptyline hcl 10 mg tablet MO 4
protriptyline hcl 5 mg tablet MO 4
quetiapine fumarate 100 mg tab MO 2 QL (90 per 30 days)
quetiapine fumarate 200 mg tab MO 2 QL (120 per 30 days)
quetiapine fumarate 25 mg tab MO 2 QL (120 per 30 days)
quetiapine fumarate 300 mg tab MO 2 QL (90 per 30 days)
quetiapine fumarate 400 mg tab MO 2 QL (90 per 30 days)
quetiapine fumarate 50 mg tab MO 2 QL (120 per 30 days)
RELAGESIC 50 MG-650 MG TABLET MO 4
revia 50 mg tablet MO 4
rhinoflex 500 mg-50 mg tablet MO 2
rhinoflex-650 50 mg-650 mg tablet MO 2
RILUTEK 50 MG TABLET MO 5
riluzole 50 mg tablet MO 4
RISPERDAL CONSTA 12.5 MG/2 ML IM SYRINGE MO 4 QL (2 per 28 days)
RISPERDAL CONSTA 25 MG/2 ML IM SYRINGE MO 4 QL (2 per 28 days)
RISPERDAL CONSTA 37.5 MG/2 ML IM SYRINGE MO 4 QL (4 per 28 days)
RISPERDAL CONSTA 50 MG/2 ML IM SYRINGE MO 5 QL (4 per 28 days)
RISPERDAL M-TAB 0.5 MG DISINTEGRATING TABLET MO 4 QL (120 per 30 days)
RISPERDAL M-TAB 1 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
RISPERDAL M-TAB 2 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
RISPERDAL M-TAB 3 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
RISPERDAL M-TAB 4 MG DISINTEGRATING TABLET MO 4 QL (60 per 30 days)
risperidone 0.25 mg odt MO 4 QL (60 per 30 days)
risperidone 0.25 mg tablet MO 2 QL (60 per 30 days)
risperidone 0.5 mg odt MO 4 QL (120 per 30 days)
risperidone 0.5 mg tablet MO 2 QL (120 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 89
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
risperidone 1 mg odt MO 3 QL (60 per 30 days)
risperidone 1 mg tablet MO 2 QL (60 per 30 days)
risperidone 1 mg/ml solution MO 2
risperidone 2 mg odt MO 4 QL (60 per 30 days)
risperidone 2 mg tablet MO 2 QL (60 per 30 days)
risperidone 3 mg odt MO 4 QL (60 per 30 days)
risperidone 3 mg tablet MO 2 QL (60 per 30 days)
risperidone 4 mg odt MO 3 QL (60 per 30 days)
risperidone 4 mg tablet MO 2 QL (60 per 30 days)
rizatriptan 10 mg odt MO 4 QL (12 per 30 days)
rizatriptan 10 mg tablet MO 4 QL (12 per 30 days)
rizatriptan 5 mg odt MO 4 QL (12 per 30 days)
rizatriptan 5 mg tablet MO 4 QL (12 per 30 days)
ROMAZICON 0.1 MG/ML VIAL MO 4
ropinirole hcl 0.25 mg tablet MO 2
ropinirole hcl 0.5 mg tablet MO 2
ropinirole hcl 1 mg tablet MO 2
ropinirole hcl 2 mg tablet MO 2
ropinirole hcl 3 mg tablet MO 2
ropinirole hcl 4 mg tablet MO 2
ropinirole hcl 5 mg tablet MO 2
ropinirole hcl er 12 mg tablet MO 3 QL (90 per 30 days)
ropinirole hcl er 2 mg tablet MO 3 QL (90 per 30 days)
ropinirole hcl er 4 mg tablet MO 3 QL (90 per 30 days)
ropinirole hcl er 6 mg tablet MO 3 QL (90 per 30 days)
ropinirole hcl er 8 mg tablet MO 3 QL (90 per 30 days)
roxicet 5 mg-325 mg tablet MO 3 QL (360 per 30 days)
ROXICET 5 MG-325 MG/5 ML ORAL SOLN MO 3 QL (1830 per 30 days)
ROXICET 5-500 CAPLET MO 3 QL (240 per 30 days)
SABRIL 500 MG ORAL POWDER IN PACKET MO 5 PA,QL (180 per 30 days)
SABRIL 500 MG TABLET MO 5 PA,QL (180 per 30 days)
salsalate 500 mg tablet MO 3
salsalate 750 mg tablet MO 3
SAPHRIS (BLACK CHERRY) 10 MG SUBLINGUAL TABLET MO 4 PA,QL (60 per 30 days)
SAPHRIS (BLACK CHERRY) 5 MG SUBLINGUAL TABLET MO 4 PA,QL (60 per 30 days)
90 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
SAPHRIS 10 MG SUBLINGUAL TABLET MO 4 PA,QL (60 per 30 days)
SAPHRIS 5 MG SUBLINGUAL TABLET MO 4 PA,QL (60 per 30 days)
SAVELLA 100 MG TABLET MO 3 QL (60 per 30 days)
SAVELLA 12.5 MG (5)-25 MG(8)-50MG(42) TABLETS IN A DOSE PACK MO 3 QL (60 per 30 days)
SAVELLA 12.5 MG TABLET MO 3 QL (60 per 30 days)
SAVELLA 25 MG TABLET MO 3 QL (60 per 30 days)
SAVELLA 50 MG TABLET MO 3 QL (60 per 30 days)
selegiline hcl 5 mg capsule MO 4
selegiline hcl 5 mg tablet MO 4
SEROQUEL XR 150 MG TABLET,EXTENDED RELEASE MO 3 QL (90 per 30 days)
SEROQUEL XR 200 MG TABLET,EXTENDED RELEASE MO 3 QL (30 per 30 days)
SEROQUEL XR 300 MG TABLET,EXTENDED RELEASE MO 3 QL (60 per 30 days)
SEROQUEL XR 400 MG TABLET,EXTENDED RELEASE MO 3 QL (60 per 30 days)
SEROQUEL XR 50 MG TABLET,EXTENDED RELEASE MO 3 QL (120 per 30 days)
sertraline 20 mg/ml oral conc MO 1
sertraline hcl 100 mg tablet MO 1 QL (60 per 30 days)
sertraline hcl 25 mg tablet MO 1 QL (90 per 30 days)
sertraline hcl 50 mg tablet MO 1 QL (90 per 30 days)
SILENOR 3 MG TABLET MO 4 QL (30 per 30 days)
SILENOR 6 MG TABLET MO 4 QL (30 per 30 days)
stagesic 5-500 capsule MO 3 QL (240 per 30 days)
STAVZOR 125 MG CAPSULE,DELAYED RELEASE MO 4
STAVZOR 250 MG CAPSULE,DELAYED RELEASE MO 4
STAVZOR 500 MG CAPSULE,DELAYED RELEASE MO 4
STRATTERA 10 MG CAPSULE MO 4 QL (60 per 30 days)
STRATTERA 100 MG CAPSULE MO 4 QL (30 per 30 days)
STRATTERA 18 MG CAPSULE MO 4 QL (60 per 30 days)
STRATTERA 25 MG CAPSULE MO 4 QL (60 per 30 days)
STRATTERA 40 MG CAPSULE MO 4 QL (60 per 30 days)
STRATTERA 60 MG CAPSULE MO 4 QL (30 per 30 days)
STRATTERA 80 MG CAPSULE MO 4 QL (30 per 30 days)
SUBOXONE 12 MG-3 MG SUBLINGUAL FILM MO 4 PA,QL (60 per 30 days)
SUBOXONE 2 MG-0.5 MG SUBLINGUAL FILM MO 4 PA,QL (90 per 30 days)
SUBOXONE 4 MG-1 MG SUBLINGUAL FILM MO 4 PA,QL (90 per 30 days)
SUBOXONE 8 MG-2 MG SUBLINGUAL FILM MO 4 PA,QL (90 per 30 days)
2014 HUMANA FORMULARY UPDATED 08/2013 - 91
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
sufentanil 250 mcg/5 ml ampul MO 3 QL (1440 per 30 days)
sulindac 150 mg tablet MO 2
sulindac 200 mg tablet MO 2
sumatriptan 20 mg nasal spray MO 4 QL (12 per 30 days)
sumatriptan 4 mg/0.5 ml cart MO 4 QL (6 per 30 days)
sumatriptan 4 mg/0.5 ml inject MO 4 QL (6 per 30 days)
sumatriptan 5 mg nasal spray MO 4 QL (12 per 30 days)
sumatriptan 6 mg/0.5 ml inject MO 4 QL (6 per 30 days)
sumatriptan 6 mg/0.5 ml refill MO 4 QL (6 per 30 days)
sumatriptan 6 mg/0.5 ml syrng MO 3 QL (6 per 30 days)
sumatriptan 6 mg/0.5 ml vial MO 4 QL (6 per 30 days)
sumatriptan succ 100 mg tablet MO 2 QL (9 per 30 days)
sumatriptan succ 25 mg tablet MO 2 QL (9 per 30 days)
sumatriptan succ 50 mg tablet MO 2 QL (9 per 30 days)
SURMONTIL 100 MG CAPSULE MO 4 PA
SURMONTIL 25 MG CAPSULE MO 4 PA
SURMONTIL 50 MG CAPSULE MO 4 PA
SYMBYAX 12 MG-25 MG CAPSULE MO 4 PA,QL (30 per 30 days)
SYMBYAX 12 MG-50 MG CAPSULE MO 4 PA,QL (30 per 30 days)
SYMBYAX 3 MG-25 MG CAPSULE MO 4 PA,QL (30 per 30 days)
SYMBYAX 6 MG-25 MG CAPSULE MO 4 PA,QL (30 per 30 days)
SYMBYAX 6 MG-50 MG CAPSULE MO 4 PA,QL (30 per 30 days)
TASMAR 100 MG TABLET MO 4 PA
TEGRETOL XR 100 MG TABLET,EXTENDED RELEASE MO 4
TEGRETOL XR 200 MG TABLET,EXTENDED RELEASE MO 4
TEGRETOL XR 400 MG TABLET,EXTENDED RELEASE MO 4
temazepam 15 mg capsule MO 4 QL (30 per 30 days)
temazepam 22.5 mg capsule MO 4
temazepam 30 mg capsule MO 4 QL (30 per 30 days)
temazepam 7.5 mg capsule MO 4
thioridazine 10 mg tablet MO 2 PA
thioridazine 100 mg tablet MO 2 PA
thioridazine 25 mg tablet MO 2 PA
thioridazine 50 mg tablet MO 2 PA
thiothixene 1 mg capsule MO 2
92 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
thiothixene 10 mg capsule MO 2
thiothixene 2 mg capsule MO 2
thiothixene 5 mg capsule MO 2
tiagabine hcl 2 mg tablet MO 4
tiagabine hcl 4 mg tablet MO 4
tolmetin sodium 200 mg tab MO 3
tolmetin sodium 400 mg cap MO 4
tolmetin sodium 600 mg tab MO 3
TOPAMAX 100 MG TABLET MO 4 QL (120 per 30 days)
TOPAMAX 15 MG SPRINKLE CAPSULE MO 4
TOPAMAX 200 MG TABLET MO 4 QL (120 per 30 days)
TOPAMAX 25 MG SPRINKLE CAPSULE MO 4
TOPAMAX 25 MG TABLET MO 4 QL (90 per 30 days)
TOPAMAX 50 MG TABLET MO 4 QL (120 per 30 days)
topiragen 100 mg tablet MO 2 QL (120 per 30 days)
topiragen 200 mg tablet MO 2 QL (120 per 30 days)
topiragen 25 mg tablet MO 2 QL (90 per 30 days)
topiragen 50 mg tablet MO 2 QL (120 per 30 days)
topiramate 100 mg tablet MO 2 QL (120 per 30 days)
topiramate 15 mg sprinkle cap MO 2
topiramate 200 mg tablet MO 2 QL (120 per 30 days)
topiramate 25 mg sprinkle cap MO 2
topiramate 25 mg tablet MO 2 QL (90 per 30 days)
topiramate 50 mg tablet MO 2 QL (120 per 30 days)
tramadol hcl 50 mg tablet MO 2 QL (240 per 30 days)
tramadol-acetaminophn 37.5-325 MO 3 QL (240 per 30 days)
tranylcypromine sulf 10 mg tab MO 4
trazodone 100 mg tablet MO 2
trazodone 150 mg tablet MO 2
trazodone 300 mg tablet MO 2
trazodone 50 mg tablet MO 2
TREXIMET 85 MG-500 MG TABLET MO 4 QL (12 per 30 days)
trifluoperazine 1 mg tablet MO 3
trifluoperazine 10 mg tablet MO 3
trifluoperazine 2 mg tablet MO 3
2014 HUMANA FORMULARY UPDATED 08/2013 - 93
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
trifluoperazine 5 mg tablet MO 3
trihexyphenidyl 2 mg tablet MO 2 PA
trihexyphenidyl 2 mg/5 ml elx MO 2 PA
trihexyphenidyl 5 mg tablet MO 2 PA
TRILEPTAL 300 MG/5 ML ORAL SUSP MO 4
trimipramine maleate 100 mg cp MO 4 PA
trimipramine maleate 25 mg cap MO 4 PA
trimipramine maleate 50 mg cap MO 4 PA
ULTIVA 1 MG IV SOLUTION MO 4 QL (450 per 30 days)
ULTIVA 2 MG IV SOLUTION MO 4 QL (240 per 30 days)
ULTIVA 5 MG IV SOLUTION MO 4 QL (90 per 30 days)
ULTRACET 37.5 MG-325 MG TABLET MO 4 QL (240 per 30 days)
valproate sod 500 mg/5 ml vl MO 2
valproic acid 250 mg capsule MO 2
valproic acid 250 mg/5 ml soln MO 2
valproic acid 500 mg/10 ml sol MO 2
venlafaxine hcl 100 mg tablet MO 3
venlafaxine hcl 25 mg tablet MO 3
venlafaxine hcl 37.5 mg tablet MO 3
venlafaxine hcl 50 mg tablet MO 3
venlafaxine hcl 75 mg tablet MO 3
venlafaxine hcl er 150 mg cap MO 2 QL (60 per 30 days)
VENLAFAXINE HCL ER 150 MG TAB MO 4 QL (30 per 30 days)
VENLAFAXINE HCL ER 225 MG TAB MO 4 QL (30 per 30 days)
venlafaxine hcl er 37.5 mg cap MO 2 QL (30 per 30 days)
venlafaxine hcl er 37.5 mg tab MO 4 QL (30 per 30 days)
venlafaxine hcl er 75 mg cap MO 2 QL (90 per 30 days)
venlafaxine hcl er 75 mg tab MO 4 QL (60 per 30 days)
VIIBRYD 10 MG (7)-20 MG (7)-40 MG(16) TABLETS IN A DOSE PACK MO 4 QL (30 per 30 days)
VIIBRYD 10 MG TABLET MO 4 QL (30 per 30 days)
VIIBRYD 20 MG TABLET MO 4 QL (30 per 30 days)
VIIBRYD 40 MG TABLET MO 4 QL (30 per 30 days)
VIMOVO 375 MG-20 MG TABLET,IMMEDIATE & DELAYED RELEASE MO 3 QL (60 per 30 days)
VIMOVO 500 MG-20 MG TABLET,IMMEDIATE & DELAYED RELEASE MO 3 QL (60 per 30 days)
VIMPAT 10 MG/ML ORAL SOLN MO 4 QL (1395 per 30 days)
94 - 2014 HUMANA FORMULARY UPDATED 08/2013
DRUG NAME TIER UTILIZATION
MANAGEMENT
REQUIREMENTS
ST - Step Therapy ? QL - Quantity Limit ? PA - Prior Authorization ? B vs D - Part B versus Part D
Need more information about the indicators displayed by the drug names? Please go to page 9.
VIMPAT 100 MG TABLET MO 4
VIMPAT 150 MG TABLET MO 4
VIMPAT 200 MG TABLET MO 4
VIMPAT 200 MG/20 ML IV MO 4
VIMPAT 50 MG TABLET MO 4
VIVITROL 380 MG IM SUSPENSION,EXTENDED RELEASE MO 5 PA
VOLTAREN 1%TOPICAL GEL MO 4
XENAZINE 12.5 MG TABLET SP 5 PA,QL (240 per 30 days)
XENAZINE 25 MG TABLET SP 5 PA,QL (120 per 30 days)
XYREM 500 MG/ML ORAL SOLN SP 5 PA,QL (540 per 30 days)
zaleplon 10 mg capsule MO 2 QL (90 per 365 days)
zaleplon 5 mg capsule MO 2 QL (90 per 365 days)
ZARONTIN 250 MG CAPSULE MO 4
ZARONTIN 250 MG/5 ML ORAL SOLN MO 4
zenzedi 10 mg tablet MO 4 QL (180 per 30 days)
ZENZEDI 2.5 MG TABLET MO 4 QL (90 per 30 days)
zenzedi 5 mg tablet MO 4 QL (150 per 30 days)
ZENZEDI 7.5 MG TABLET MO 4 QL (90 per 30 days)
zgesic 66 mg-600 mg tablet,extended release MO 2
ziprasidone hcl 20 mg capsule MO 4 QL (60 per 30 days)
ziprasidone hcl 40 mg capsule MO 4 QL (60 per 30 days)
ziprasidone hcl 60 mg capsule MO 4 QL (60 per 30 days)
ziprasidone hcl 80 mg capsule MO 4 QL (60 per 30 days)
zolpidem tartrate 10 mg tablet MO 1 QL (90 per 365 days)
zolpidem tartrate 5 mg tablet MO 1 QL (90 per 365 days)
zonisamide 100 mg capsule MO 2
zonisamide 25 mg capsule MO 2
zonisamide 50 mg capsule MO 2
ZYBAN 150 MG TABLET,SUSTAINED-RELEASE MO 3 QL (90 per 30 days)
ZYPREXA 10 MG IM MO 4 QL (60 per 30 days)
ZYPREXA RELPREVV 210 MG IM SUSP MO 4 PA,QL (2 per 28 days)
ZYPREXA RELPREVV 300 MG IM SUSP MO 5 PA,QL (2 per 28 days)
ZYPREXA RELPREVV 405 MG IM SUSP MO 5 PA,QL (1 per 28 days)
DEVICES